This is a multi-national, multi-centre, randomized study comparing the trans-radial PCI access strategy and the trans-femoral PCI access strategy in ACS patients with UA or NSTEMI or STEMI planned to be treated with an invasive strategy (PCI). The hypothesis is that radial access site PCI will be associated with significantly less major bleeding and access site complications compared with a femoral approach, without increasing the risk of ischemic events. The overall benefit-risk profile will favor a trans-radial approach.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
7,021
Hamilton Health Sciences
Hamilton, Ontario, Canada
First occurrence of the composite of death, MI, stroke or non CABG major bleeding (i.e. severe bleeding, other major bleeding) at 30 days.
Time frame: 30 days
Non CABG major bleeding
Time frame: within 30 days following randomization
Death, MI or stroke
Time frame: within 30 days following randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.